National and Kapodistrian University of Athens
Η αντιμετώπιση του καρκινικού νευροπαθητικού πόνου με τη χρήση της πρεγκαμπαλίνης
Abstract
dc:descriptionThe aim of this dissertation was to assess whether the use of an “adjuvant” (such as pregabalin) should be preferred to the use of a strong opioid for the management of patients with neuropathic cancer pain. We conducted a randomized, head-to-head study in patients with moderate-to-severe “definite” neuropathic cancer pain in which we compared the use of fentanyl (group A) to the use of pregabalin (group B) when both were added on a basic analgesic regimen. We also studied the use of the DN4 questionnaire for screening purposes, as well as the effectiveness of the WHO analgesic scale, in this type of pain. We showed that pregabalin is more effective and better tolerated than fentanyl, as well as that the DN4 may be utilized for screening purposes, in this type of pain. Furthermore, the WHO scale remains valid assuming that diagnosis is specifically defined. Concluding, in patients with neuropathic cancer pain, it is preferable to remain on the second step of the WHO scale, adding pregabalin, than to move to step 3 with the addition if a strong opioid.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2014
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Raptis, Efkleidis
- Ράπτης, Ευκλείδης
Subjects
dc:subject × 13Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/39931